The thrombopoietin mimetic romiplostim leads to the complete rescue of mice exposed to lethal ionizing radiation

Scientific Reports
Masaru YamaguchiIkuo Kashiwakura

Abstract

For the primary treatment of emergency exposure to high-dose radiation, such as in the event of a radiation accident, the top priority is the reconstitution and restoration of haematopoiesis. In most radiation accidents, drug therapy is chosen as the most suitable treatment; the chosen drug should already be approved domestically, stably supplied and regularly stockpiled. In the present study, a single administration of romiplostim (RP), an approved thrombopoietin receptor agonist, produced a 100% survival rate in C57BL/6 J mice exposed to a lethal dose (7 Gy) of 137Cs γ-rays, and all irradiated mice survived for more than 30 days with both 3- and 5-day consecutive administrations. By day 30, the peripheral blood cells, bone marrow cells and haematopoietic progenitor cells of the RP-administered irradiated mice had all recovered to a level that was not significantly different from that in non-irradiated mice. In contrast to myelosuppression, which did not fully recover until day 30, the expression of several bone marrow cell surface antigens recovered sooner, and DNA repair concurrently increased in haematopoietic cells, speeding the resolution of double strand breaks and reducing the rates of apoptosis. These findings suggest ...Continue Reading

References

Apr 23, 1988·Lancet·R P Gale, Y Reisner
Mar 31, 1999·International Journal of Radiation Oncology, Biology, Physics·M A MouthonG Wagemaker
Jun 1, 2002·Science·David S Aaronson, Curt M Horvath
Aug 17, 2002·Canadian Journal of Physiology and Pharmacology·Marc-André MouthonMarie-Hélène Gaugler
Nov 25, 2003·Hematology·Nicholas DainiakAnn M Farese
Jun 15, 2004·Experimental Cell Research·Bert SchutteFrans C S Ramaekers
Jun 16, 2004·Annals of Internal Medicine·Jamie K WaselenkoUNKNOWN Strategic National Stockpile Radiation Working Group
Jul 3, 2004·Nature Reviews. Drug Discovery·John J O'SheaPaul S Changelian
Feb 17, 2006·Journal of Translational Medicine·John M NinosWilliam G Kerr
Nov 3, 2009·Nature·Michael J KeiserBryan L Roth
Mar 26, 2010·Radiation Research·Jacqueline P WilliamsWilliam H McBride
Aug 30, 2012·Health Physics·P Artur PlettChristie M Orschell
Jan 12, 2013·Science·Michal ZimmermannTitia de Lange
Oct 8, 2013·Trends in Cell Biology·Michal Zimmermann, Titia de Lange
Jan 25, 2014·Blood·Atsushi Hirao
Dec 17, 2014·The Journal of Pharmacology and Experimental Therapeutics·John E BakerGarrett J Gross
Nov 17, 2015·Nature·Christopher N InraSean J Morrison
Apr 12, 2017·Frontiers in Immunology·Tünde SzatmáriKatalin Lumniczky

❮ Previous
Next ❯

Citations

Apr 26, 2019·International Journal of Radiation Biology·Deborah I BuninPolly Y Chang
Jun 4, 2021·Drug Design, Development and Therapy·James B BusselJohn W Semple
Aug 18, 2021·International Journal of Radiation Biology·Vijay K Singh, Thomas M Seed

❮ Previous
Next ❯

Methods Mentioned

BETA
FACS
X-ray
fluorescence-activated cell sorting

Software Mentioned

Excel
Statcel

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.